Literature DB >> 18974639

Comparing measures of cystatin C in human sera by three methods.

Mohammad Akhtar Hossain1, Mahmoud Emara, Hamdi El Moselhi, Ahmed Shoker.   

Abstract

BACKGROUND: Cystatin C (Cys C) is measured by particle-enhanced nephelometric immunoassay (PENIA), particle-enhanced turbidimetric immunoassay (PETIA) and ELISA. AIM: To determine differences among these methods.
METHOD: 80 normal human sera and 20 from patients with renal and/or heart disease were simultaneously assayed. Statistical analyses including receiver operating characteristics (ROC) of the three methods were compared.
RESULTS: There was a highly significant correlation across the assay range between the ELISA and PENIA (r(2) = 0.94) and PETIA methods (r(2) = 0.95). Analysis of variance and bias were poor between the ELISA and the other two methods. Mean difference between ELISA and PETIA was 0.65 +/- 0.63 microg/ml, while it was 0.58 +/- 0.53 microg/ml between ELISA and PENIA. Accuracy (at 30% range) was 17 and 11% between ELISA and PETIA and ELISA and PENIA, respectively. Normalization of the ELISA by a factor of 0.66 improved this relationship. AUC of ROC curves of PENIA, ELISA and normalized ELISA to predict Cys C levels measured from PETIA were all above 0.87 (p = not significant between curves). Criterion values of ELISA*.66 method was close to PETIA measurements.
CONCLUSION: There is a significant difference in measured human Cys C levels among the three methods, and normalization of ELISA narrows these differences. Copyright (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18974639     DOI: 10.1159/000168486

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  12 in total

Review 1.  Cystatin C in newborns: a promising renal biomarker in search for standardization and validation.

Authors:  Karel Allegaert; Djalila Mekahli; John van den Anker
Journal:  J Matern Fetal Neonatal Med       Date:  2014-11-05

2.  First-year profile of biomarkers for early detection of renal injury in infants with congenital urinary tract obstruction.

Authors:  Dusan Kostic; Glenda Priscila Neves Dos Santos Beozzo; Saulo Brasil do Couto; André Henrique Teruaki Kato; Laila Lima; Patricia Palmeira; Vera Lúcia Jornada Krebs; Victor Bunduki; Rossana Pulcineli Vieira Francisco; Marcelo Zugaib; Werther Brunow de Carvalho; Vera Hermina Kalika Koch
Journal:  Pediatr Nephrol       Date:  2019-01-29       Impact factor: 3.714

3.  The impact of interlaboratory differences in cystatin C assay measurement on glomerular filtration rate estimation.

Authors:  Christine A White; Andrew D Rule; Christine P Collier; Ayub Akbari; John C Lieske; Nathalie Lepage; Steve Doucette; Greg A Knoll
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-28       Impact factor: 8.237

Review 4.  Cystatin C: a step forward in assessing kidney function and cardiovascular risk.

Authors:  Johan Lassus; Veli-Pekka Harjola
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

Review 5.  Cystatin C as a potential biomarker for dosing of renally excreted drugs.

Authors:  Nguessan Aimé Brou; Evelyne Jacqz-Aigrain; Wei Zhao
Journal:  Br J Clin Pharmacol       Date:  2015-05-28       Impact factor: 4.335

6.  Comparison of Aptamer-Based and Antibody-Based Assays for Protein Quantification in Chronic Kidney Disease.

Authors:  Carolina Lopez-Silva; Aditya Surapaneni; Josef Coresh; Jochen Reiser; Chirag R Parikh; Wassim Obeid; Morgan E Grams; Teresa K Chen
Journal:  Clin J Am Soc Nephrol       Date:  2022-02-23       Impact factor: 10.614

7.  A Novel Targeted Screening Tool for Hypogammaglobulinemia: Measurement of Serum Immunoglobulin (IgG, IgM, IgA) Levels from Dried Blood Spots (Ig-DBS Assay).

Authors:  Leman Yel; Christopher J Rabbat; Charlotte Cunningham-Rundles; Jordan S Orange; Troy R Torgerson; James W Verbsky; Yeong Wang; Maoyong Fu; Terry S Robins; Marc S Edwards; Jesper Nymann-Andersen
Journal:  J Clin Immunol       Date:  2015-08-16       Impact factor: 8.317

8.  Serum cystatin C is a poor biomarker for diagnosing acute kidney injury in critically-ill children.

Authors:  Hanan M Hamed; Seham Awad El-Sherbini; Nahla A Barakat; Tarek M Farid; Enas Abdel Rasheed
Journal:  Indian J Crit Care Med       Date:  2013-03

9.  Serum cystatin C and tubular urinary enzymes as biomarkers of renal dysfunction in type 2 diabetes mellitus.

Authors:  Heba S Assal; Salwa Tawfeek; Enas A Rasheed; Dalia El-Lebedy; Eman H Thabet
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2013-07-31

10.  Comparison between a serum creatinine-and a cystatin C-based glomerular filtration rate equation in patients receiving amphotericin B.

Authors:  Iman Karimzadeh; Hossein Khalili
Journal:  Daru       Date:  2016-06-06       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.